Recently, TGF-beta signaling has been implicated in antidepressant effects of ketamine where reduced expressions of Tgfb1 and its receptors in a rodent model of depression was ameliorated by ketamine administration35. This evidence concerns the gene TGFB1 and major depressive disorder.